Tumor-inhibitory effect of a streptococcal preparation (NSC-B116209).
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use* / Q000633:toxicity; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy; D002415:Cats; D002478:Cells, Cultured; D004285:Dogs; D005260:Female; D005612:Freeze Drying; D006168:Guinea Pigs; D000882:Haplorhini; D007928:Lethal Dose 50; D007939:Leukemia L1210 / Q000188:drug therapy; D008113:Liver Neoplasms; D008251:Macaca; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009374:Neoplasms, Experimental / Q000188:drug therapy; D010400:Penicillin G / Q000627:therapeutic use; D011817:Rabbits; D051381:Rats; D011919:Rats, Inbred Strains; D012517:Sarcoma, Yoshida / Q000188:drug therapy; D013291:Streptococcus
D000903:Antibiotics, Antineoplastic; D010400:Penicillin G